Nabulsi Azmi — SEC Form 4 filings

SEC reporting owner CIK 1791412. 6 Form 4 filings on record with FilingPulse; latest filed 2025-03-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-01-22 to 2025-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Phathom Pharmaceuticals, Inc. (PHAT)Chief Operating Officer63 legs · 19,905 sh · $188,6614

Form 4 filings — Nabulsi Azmi

FiledFormIssuerReported transactionsSource
2025-03-034Phathom Pharmaceuticals, Inc. (PHAT)Grant/award (A): 79,200 @ $0 · Grant/award (A): 55,000 (derivative) @ $0EDGAR
2025-01-234Phathom Pharmaceuticals, Inc. (PHAT)Sale (S): 7,886 @ $6.59EDGAR
2024-12-204Phathom Pharmaceuticals, Inc. (PHAT)Sale (S): 1,118 @ $8EDGAR
2024-07-174Phathom Pharmaceuticals, Inc. (PHAT)Sale (S): 10,901 @ $11.72EDGAR
2024-05-314Phathom Pharmaceuticals, Inc. (PHAT)Grant/award (A): 7,500 @ $0EDGAR
2024-01-224Phathom Pharmaceuticals, Inc. (PHAT)Grant/award (A): 130,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791412 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →